Literature DB >> 28488097

Feasibility of measurements of valve dimensions in en-face-3D transesophageal echocardiography.

Sarah Eibel1, Edwin Turton2, Chirojit Mukherjee3, Carmine Bevilacqua2, Joerg Ender4.   

Abstract

Newest 3D software allows measurements directly in the en-face-3D TEE mode. Aim of the study was to ascertain whether measurements performed in the en-face-3D TEE mode are comparable with conventional measurement methods based on 2D TEE and 3D using the multiple plane reconstruction mode with the Qlab® software. En-face-3D TEE is used more frequently in daily clinical routine during cardiac operations. So far measurements could only be done based on 2D images or with the use of multi planar reconstruction mode with additional software. Measurement directly in the 3D image (en-face-3D TEE) would make measurements faster and easier to use in clinical practice. After approval by the local ethic committee and written informed consent from the patients additionally to a comprehensive perioperative 2D TEE examination a real time (RT) 3D zoom- dataset was recorded. Routine measurements of the length of anterior and posterior mitral valve leaflets as well as mitral valve and aortic valve areas were performed in en-face-3D TEE, multiplanar reconstruction mode using Qlab®-software (Philips, Netherlands) and 2D TEE standard views. Twenty nine patients with a mean age of 67 years undergoing elective cardiac surgery/interventions were enrolled in this study. Direct measurements in en-face-3D TEE mode lead to non significant underestimation of all parameters as compared to Qlab® and 2D TEE measurements. Measurements in en-face-3D TEE are feasible but lead to non significant underestimation compared to measurements performed with Qlab® or in 2D TEE views.

Entities:  

Keywords:  2D TEE; En-face-3D TEE; Heart valve disease; Intraoperative 3D imaging; RT 3D TEE

Mesh:

Year:  2017        PMID: 28488097     DOI: 10.1007/s10554-017-1141-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography.

Authors:  Roberto M Lang; Luigi P Badano; Wendy Tsang; David H Adams; Eustachio Agricola; Thomas Buck; Francesco F Faletra; Andreas Franke; Judy Hung; Leopoldo Pérez de Isla; Otto Kamp; Jaroslaw D Kasprzak; Patrizio Lancellotti; Thomas H Marwick; Marti L McCulloch; Mark J Monaghan; Petros Nihoyannopoulos; Natesa G Pandian; Patricia A Pellikka; Mauro Pepi; David A Roberson; Stanton K Shernan; Girish S Shirali; Lissa Sugeng; Folkert J Ten Cate; Mani A Vannan; Jose Luis Zamorano; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2012-01       Impact factor: 5.251

Review 2.  3D echocardiography: a review of the current status and future directions.

Authors:  Judy Hung; Roberto Lang; Frank Flachskampf; Stanton K Shernan; Marti L McCulloch; David B Adams; James Thomas; Mani Vannan; Thomas Ryan
Journal:  J Am Soc Echocardiogr       Date:  2007-03       Impact factor: 5.251

3.  Four-dimensional modelling of the mitral valve by real-time 3D transoesophageal echocardiography: proof of concept.

Authors:  Thilo Noack; Chirojit Mukherjee; Philipp Kiefer; Fabian Emrich; Marcel Vollroth; Razvan Ioan Ionasec; Ingmar Voigt; Helene Houle; Joerg Ender; Martin Misfeld; Friedrich Wilhelm Mohr; Joerg Seeburger
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-10-31

4.  [Real-time 3 dimensional full volume data set : benefits in problem focused intraoperative transesophageal echocardiography].

Authors:  A Ender; S Eibel; E Hasheminejad; M Scholz; U X Kaisers; C Mukherjee; J Ender
Journal:  Anaesthesist       Date:  2012-10-20       Impact factor: 1.041

Review 5.  Clinical application of three-dimensional echocardiography.

Authors:  Caroline Morbach; Ben A Lin; Lissa Sugeng
Journal:  Prog Cardiovasc Dis       Date:  2014-05-20       Impact factor: 8.194

6.  Transesophageal echocardiography during MitraClip® procedure.

Authors:  Fabio Guarracino; Rubia Baldassarri; Baldassare Ferro; Cristina Giannini; Pietro Bertini; Anna Sonia Petronio; Vitantonio Di Bello; Giovanni Landoni; Ottavio Alfieri
Journal:  Anesth Analg       Date:  2014-06       Impact factor: 5.108

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Three-dimensional echocardiographic assessment of the repaired mitral valve.

Authors:  Andrew Maslow; Feroze Mahmood; Athena Poppas; Arun Singh
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-09-25       Impact factor: 2.628

9.  Real-time three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation: an accurate and novel approach.

Authors:  José Zamorano; Pedro Cordeiro; Lissa Sugeng; Leopoldo Perez de Isla; Lynn Weinert; Carlos Macaya; Enrique Rodríguez; Roberto M Lang
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

10.  Real-time three-dimensional transesophageal echocardiography in the intraoperative assessment of mitral valve disease.

Authors:  Jasmine Grewal; Sunil Mankad; William K Freeman; Roger L Click; Rakesh M Suri; Martin D Abel; Jae K Oh; Patricia A Pellikka; Gillian C Nesbitt; Imran Syed; Sharon L Mulvagh; Fletcher A Miller
Journal:  J Am Soc Echocardiogr       Date:  2009-01       Impact factor: 5.251

View more
  2 in total

1.  Three-dimensional transesophageal echocardiography measurement of mitral valve area in patients with rheumatic mitral stenosis: multiplanar reconstruction or 3D direct planimetry?

Authors:  Xinbo Zhong; Wenbin Chen; Zhiyong Shi; Zhifu Huan; Lanxiang Ma; Wei Liu; Xiaohan Yang; Yan Xu; Yong Jiang; Alex Pui-Wai Lee; Ruiqiang Guo
Journal:  Int J Cardiovasc Imaging       Date:  2020-07-27       Impact factor: 2.357

Review 2.  Role of 3D Echocardiography in Cardiac Surgery: Strengths and Limitations.

Authors:  Edwin Wilberforce Turton; Jörg Ender
Journal:  Curr Anesthesiol Rep       Date:  2017-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.